CXCL9 and CXCL10 are presented in high levels in serum and CSF of patients with HAM/TSP and contribute to the pathogenesis of HAM/TSP (Sato et al., 2013; Guerra et al., 2018). Here, CXCL10 is linked to tropical spastic paraparesis.